These MyHep LVIR Tablets are highly recognized in the healthcare sector as the simplified single tablet used in once-daily treatment regimen. The medicine contains the active ingredient ledipasvir which is indicated for the treatment of hepatitis C infection. In addition, it also eliminates the requirement of interferon and ribavirin in the treatment. This medicine exhibits high cure rates and a tolerable side effect profile in patients.
VEA IMPEX is engaged in Export of Pharmaceutical Products (Branded Generics, Specialty Products) to global markets. Over one and half decade of experience in exports of pharmaceutical products and the distribution industry has helped us build strong relationships with our suppliers. Our learning and growing process is ever evolving, as we are moving hand in hand with our old partnerships and also making new alliances. We work for companies that follow international standards under the conditions of Good Manufacturing Practice (GMP), so the quality is of the high standards. This ensures that quality products are supplied to the clients. Health care professionals around the world can depend upon us, as our pharmaceutical exports division sources and supplies branded medicines to them as and when required. Generic Pharmaceutical Medicines manufactured under Product Licence / Marketing Authorisations can also be arranged for the clients. Our team is fully equipped to cater to needs for documentations as required for registrations in overseas countries.
- BUSINESS TYPE Exporter, Supplier, Trading Company, Wholesaler, Retailer, Dealer
- EMPLOYEE COUNT 15
- ESTABLISHMENT 2014
- ANNUAL TURNOVER Rs 100 Lakhs
- WORKING DAYS Monday To Saturday
- GST NO 27AALFV8912H1ZP